Strongyloidiasis control programs in highly endemic areas: an economic analysis of different approaches | Infectious diseases of poverty

0


[ad_1]

  • 1.

    Krolewiecki AJ, Lammie P, Jacobson J, Gabrielli AF, Levecke B, Socias E, et al. A public health response against Strongyloides stercoralis: It’s time to take a closer look at soil-transmitted helminths. PLoS Negl Too Say. 2013; 7 (5): e2165.

    Item

    Google Scholar

  • 2.

    Buonfrate D, Bisanzio D, Giorli G, Odermatt P, Fürst T, Greenaway C, et al. The global prevalence of Strongyloides stercoralis infection. Pathogens (Basel, Switzerland). 2020; 9 (6): 468.

    PubMed Central

    Google Scholar

  • 3.

    Montresor A, Mupfasoni D, Mikhailov A, Mwinzi P, Lucianez A, Jamsheed M, et al. Global progress in STH control in 2020 and the World Health Organization’s goals for 2030. PLoS Negl Trop Dis. 2020; 14 (8): e0008505.

    Item

    Google Scholar

  • 4.

    Fleitas PE, Travacio M, Martí-Soler H, ME companies, Lopez WR, Krolewiecki AJ. The Strongyloides stercoralis– The association of hookworms as a means of estimating the global burden of strongyloidiasis: a systematic review. PLoS Negl Too Say. 2020; 14 (4): e0008184.

    Item

    Google Scholar

  • 5.

    Buonfrate D, Formenti F, Perandin F, Bisoffi Z. New approaches to the diagnosis of Strongyloides stercoralis infection. Clin Microbiol Infect. 2015; 21 (6): 543–52.

    CASE
    Item

    Google Scholar

  • 6.

    Formenti F, Buonfrate D, Prandi R, Marquez M, Caicedo C, Rizzi E, et al. Comparison of S. stercoralis serology performed on dried blood drops and on conventional serum samples. Microbiol before. 2016; 7: 1778.

    Item

    Google Scholar

  • 7.

    Mounsey K, Kearns T, Rampton M, Llewellyn S, King M, Holt D, et al. Use of dried blood drops to define the antibody response to the Strongyloides stercoralis recombinant NIE antigen. Acta too. 2014; 138: 78-82.

    CASE
    Item

    Google Scholar

  • 8.

    WHO, Diagnostic methods for the control of strongyloidiasis 2020; Virtual meeting. Ed WHO, Geneva, Switzerland.

  • 9.

    Henriquez-Camacho C, Gotuzzo E, Echevarria J, White AC Jr, Terashima A, Samalvides F, et al. Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. Cochrane Database Syst Rev. 2016; 2016 (1): CD007745.

    PubMed Central

    Google Scholar

  • ten.

    Bradley M, Taylor R, Jacobson J, Guex M, Hopkins A, Jensen J, et al. Drug donation programs supporting the global campaign to end the burden of neglected tropical diseases. Trans R Soc Trop Med Hyg. 2021. PubMed PMID: 33452881. Epub 2021/01/17. ing.

  • 11.

    Omura S. Ivermectin: 25 years old and still going strong. Intj Antimicrobagents. 2008; 31 (2): 91-8.

    CASE

    Google Scholar

  • 12.

    Chosidow A, Gendrel D. [Safety of oral ivermectin in children]. Arch pediatr: official organ of the French Pediatric Society. 2016; 23 (2): 204-9. PubMed PMID: 26697814. Epub 2015-12-25. Tolerance of oral ivermectin in children. fre.

  • 13.

    Population pyramids of the world from 1950 to 2100. https://www.populationpyramid.net/africa/2019/. Accessed February 23, 2021.

  • 14.

    Knopp S, Person B, Ame SM, Ali SM, Muhsin J, Juma S, et al. Praziquantel coverage in schools and communities targeted for urogenital schistosomiasis elimination in Zanzibar: a cross-sectional survey. Parasite vectors. 2016; 9: 5.

    Item

    Google Scholar

  • 15.

    Buonfrate D, Salas-Coronas J, Muñoz J, Maruri BT, Rodari P, Castelli F, et al. Multidose versus single dose ivermectin for Strongyloides stercoralis infection (Strong Treat 1 to 4): a multicenter, open-label, phase 3, randomized, controlled trial. Lancet Infect dis. 2019; 19 (11): 1181-90.

    CASE
    Item

    Google Scholar

  • 16.

    Khieu V, Hattendorf J, Schär F, Marti H, Char MC, Muth S, et al. Strongyloides stercoralis infection and reinfection in a cohort of children in Cambodia. Parasitol Int. 2014; 63 (5): 708–12.

    Item

    Google Scholar

  • 17.

    Salvador F, Treviño B, Chamorro-Tojeiro S, Sánchez-Montalvá A, Herrero-Martínez JM, Rodríguez-Guardado A, et al. Imported strongyloidosis: data from 1245 cases recorded in the Spanish collaborative network + REDIVI (2009-2017). PLoS NTD. 2019; 13 (5): 0007399.

    Google Scholar

  • 18.

    Buonfrate D, Requena-Mendez A, Angheben A, Muñoz J, Gobbi F, Van Den Ende J, et al. Severe strongyloidosis: a systematic review of case reports. BMC Infect Dis. 2013; 13: 78.

    Item

    Google Scholar

  • 19.

    Turner HC, Osei-Atweneboana MY, Walker M, Tettevi EJ, Churcher TS, Asiedu O, et al. The cost of community-managed annual versus biannual treatment of onchocerciasis with ivermectin: Ghana as a case study. PLoS NTD. 2013; 7 (9): e2452.

    Google Scholar

  • 20.

    Montresor A, Gabrielli AF, Diarra A, Engels D. Estimation of the cost of large-scale school deworming programs with benzimidazoles. Trans R SocTrop Med Hyg. 2010; 104 (2): 129-32.

    CASE
    Item

    Google Scholar

  • 21.

    Bisoffi Z, Buonfrate D, Sequi M, Mejia R, Cimino RO, Krolewiecki AJ, et al. Diagnostic accuracy of five serological tests for Strongyloides stercoralis infection. PLoS NTD. 2014; 8 (1): e2640.

    Google Scholar

  • 22.

    Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv Parasitol. 2004; 58: 197-288.

    Item

    Google Scholar

  • 23.

    Speich B, Ali SM, Ame SM, Bogoch II, Alles R, Huwyler J, et al. Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate and mebendazole alone against Trichuris trichiura and concomitant soil-borne helminth infections: a four-armed randomized controlled trial. Lancet Infect Dis. 2015; 15 (3): 277–84.

    CASE
    Item

    Google Scholar

  • 24.

    Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The fight against scabies in public health: research and action priorities. Lancet (London, England). 2019; 394 (10192): 81–92.

    Item

    Google Scholar

  • 25.

    Blok DJ, Kamgno J, Pion SD, Nana-Djeunga HC, Niamsi-Emalio Y, Chesnais CB, et al. Feasibility of onchocerciasis elimination using a “test-do-not-treat” strategy in areas co-endemic with Loa loa. Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa1829.

    Item
    PubMed
    PubMed Central

    Google Scholar

  • 26.

    Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet (London, England). 2010; 376 (9747): 1175–85.

    Item

    Google Scholar

  • 27.

    Strunz EC, Addiss DG, Stocks ME, Ogden S, Utzinger J, Freeman MC. Water, sanitation, hygiene and soil-borne helminthiasis: a systematic review and meta-analysis. PLoS Med. 2014; 11 (3): e1001620.

    Item

    Google Scholar

  • [ad_2]

    Share.

    Comments are closed.